Vertex Pharma (VRTX) Tops Q4 EPS by 50c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus
Go back to Vertex Pharma (VRTX) Tops Q4 EPS by 50c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 508.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $508.34 | 52 Week High | $134.71 | |||
| Open | $508.34 | 52 Week Low | $73.31 | |||
| Day High | $508.34 | P/E | N/A | |||
| Day Low | $508.34 | EPS | $-1.98 | |||
| Volume | 666 | |||||
